“Molecular Docking Study of α-, β-, and γ-Mangostin from Mangosteen (Garcinia Mangostana L.) Targeting VEGFR-2 and NRP-1 for Anti-Angiogenic Therapeutics in Retinopathy Diabetic”. 2025. The Eurasia Proceedings of Health, Environment and Life Sciences 17 (August): 10-21. https://doi.org/10.55549/ephels.145.